Legend Capital, established in 2001 and based in Beijing, China, is a prominent venture capital firm and a subsidiary of Legend Holdings Ltd. The firm focuses on investing in high-growth ventures primarily within China or related markets, managing approximately US$700 million across multiple funds. Legend Capital emphasizes early-stage investments in the information technology sector, particularly in network applications and services, as well as in infrastructure and professional services. Additionally, it targets mid-market growth companies in consumer goods, clean technology, healthcare, equipment manufacturing, and modern services. With a portfolio of over 60 companies, Legend Capital actively supports its investments by providing extensive business resources and tailored services, aimed at enhancing business development and brand building in the Chinese market.
10/F, Tower A, Raycom Info.Tech Center, No.2 Ke Xue Yuan Nanlu, Zhong Guan Cun, Haidian District, Beijing 100190, China
Daqing Cai
Managing Director
Hao Chen
Managing Director and Head of Investment
Raymond CHEN
Co-Chief Investment Officer
Rui Chen
Managing Director
Frank Hong
Managing Director
Henry Ji
Executive Director
Yi Kang
Director
Richard Li
President
Jiaqing Li
Managing Director
Xiangyu Ouyang
Managing Director
Joon Sung Park
Executive Director
FAN Qihui
Executive Director
Jenking Shao
Managing Director and Partner
Zhenxing Shao
Partner / Managing Director
Jeff Wang
Managing Director
Junfeng Wang
Managing Director
Nengguang Wang
Managing Director and CFO
Piau-Voon Wang
COO
Tony WANG
VP
Ge Xinyu
Managing Director
Quan Zhou
Managing Director, Partner
Hank Zhou
Executive Director
Hongbin Zhou
Managing Director
William Wen
Executive Director
Past deals in Growth Stage
Volant Aerotech
Series B in 2024
Volant Aerotech is a company specializing in the R&D, manufacturing, and service of passenger eVTOL, an electric vertical take-off and landing aircraft.
Angitia Biopharmaceuticals
Series C in 2024
Angitia Biopharmaceuticals is a global biotechnology company dedicated to discovering and developing innovative therapeutics for serious musculoskeletal diseases. The company focuses on researching and creating breakthrough therapies aimed at treating conditions affecting bones, muscles, and joints. By prioritizing the development of novel drugs, Angitia Biopharmaceuticals aims to improve patient outcomes and facilitate recovery from severe musculoskeletal ailments.
Hohem
Series B in 2024
Hohem is a camera gimbal developer specialized in the research, development, and design of drone flight control and image stabilization systems. Its key products are automatic face tracking shooting stabilizer, Bat vision positioning multi-rotor flight control system, Bfly multi-rotor flight control system, and Bee cross-country multi-rotor flight control system.
Leapstack
Series C in 2023
Leapstack is an insurance technology company based in Shanghai, with additional offices in Beijing and Nanjing. Founded in February 2016, it focuses on developing big data artificial intelligence solutions tailored for commercial insurance companies and social security management agencies. The company's platform enhances the insurance claims process by offering services such as risk control monitoring, post-medical reimbursement, anti-fraud measures, and compliance identification. By addressing inefficiencies in the industry, Leapstack aims to improve operational effectiveness and provide comprehensive data analysis and management tools for its clients.
Angitia Biopharmaceuticals
Series B in 2023
Angitia Biopharmaceuticals is a global biotechnology company dedicated to discovering and developing innovative therapeutics for serious musculoskeletal diseases. The company focuses on researching and creating breakthrough therapies aimed at treating conditions affecting bones, muscles, and joints. By prioritizing the development of novel drugs, Angitia Biopharmaceuticals aims to improve patient outcomes and facilitate recovery from severe musculoskeletal ailments.
Zhipu AI
Series B in 2023
Zhipu AI is a data company focused on developing an AI-based large model platform that offers API services tailored to various customer needs. The company provides a range of smart application products, including the scientific and technological information analysis engine "AMiner" and AI cognitive engines such as CodeGeeX and CogView. These tools are designed to help users automate and optimize digital tasks, thereby reducing the required manual labor. Zhipu AI's advanced applications are built on its General Language Model (GLM) series, capable of handling tasks in both Chinese and English, making its offerings versatile and applicable across different linguistic contexts.
HC Scientific
Series B in 2023
HC Scientific (Chengdu) L.L.C., founded in early 2016, focuses on developing intelligent solutions within the life sciences sector. The company aims to be a trusted partner for global clients by offering innovative products, including genetic testing instruments, reagents, and software. These products are primarily used in clinical molecular diagnostics, health gene testing, and agricultural molecular breeding. HC Scientific is recognized as a national high-tech enterprise, emphasizing autonomous research and the development of intellectual property. The company participates in significant national and provincial scientific initiatives and is supported by a team of experts, including returning PhDs. Its product offerings streamline complex tasks for life science practitioners, delivering high-throughput, automated, and cost-effective genetic testing solutions while creating value for collaborative partners.
Jinqirui Biology
Series C in 2023
Jinqirui Biology is a biotechnology company that focuses on the research and development, manufacturing, production & sales of vitro diagnostics equipment and reagents.
Tailan New Energy
Series B in 2023
Tailan New Energy is co-founded by lithium battery R&D experts introduced by the national high-level overseas talent project and a senior domestic industrialization team, focusing on the technological development and industrialization of new solid-state lithium batteries and key lithium battery materials.
Open Source China
Series B in 2023
Open Source China is a prominent community focused on open source technology, providing a platform for IT developers to discover, utilize, and exchange open source software. The community offers various resources, including open source software libraries, code sharing, discussion forums, and collaborative translation services. It serves as a hub for technical support, allowing users to seek answers to software-related questions and access relevant information. By fostering collaboration and knowledge sharing, Open Source China promotes the development and application of open source technologies among domestic developers, enhancing their ability to innovate and improve these technologies.
Bio-Engine
Series C in 2023
Bio-Engine is a developer of high-density serum-free suspension culture technology for animal cells. Its main products include HEK293 cell serum-free medium, PK15 cell serum-free medium, etc., which can be applied to antibodies, recombinant proteins, human and livestock. Virus vaccine, cell therapy and other fields.
TriApex
Series C in 2023
TriApex is an innovative CRO dedicated to providing disease-oriented one-stop solutions to enable R&D for global pharmaceutical enterprises and research institutions.
DentaFilm
Series B in 2023
DentaFilm is a provider of oral intelligent equipment and a full-chain platform (FICP), concentrating on the advancement of both digital cloud platforms and oral intelligent equipment. It focuses on oral equipment for data collection, data storage, data transmission, data management, and data applications, covering clinic 2D, and 3D image data, CAD/ CAM design, clinic ERP system, PMS, equipment IoT intelligent management.
Rongke Power
Series B in 2023
Rongke Power offers production services for energy storage battery equipment. They sell items from the VPower, TPower, and UPowertm ranges, among other product lines. is a provider of services and a fully independent intellectual property right.
Tripod Preclinical Research
Funding Round in 2023
Tripod is a Contract Research Organization in the biopharmaceutical space that provides preclinical research services for global pharma companies, R&D enterprises and institutes, and medical device developers. Tripod (TPR) is dedicated to nonclinical research (drug safety evaluation) for the candidates of new chemical entity (NCE), food additives, biologics,pesticides,veterinary drugs, and new cosmetics.
ZStack
Series C in 2023
ZStack is a provider of cloud computing services focused on making cloud technology more accessible for enterprises across various industries, including government, finance, education, and manufacturing. The company offers a range of solutions, including private and hybrid cloud systems, mini hyper-converged machines, and a cloud management platform. Additionally, ZStack provides enterprise-class distributed storage and other cloud-related products, enabling businesses to manage their data center resources—covering computing, networking, and storage—under a unified framework. With a client base of over 2,500 enterprise users, ZStack has also formed partnerships with more than 250 cloud vendors to enhance its ecosystem and channel offerings.
SJ Semi
Series C in 2023
SJ Semi is a MEOL foundry focused on front-end wafer manufacturing and quality systems. The company specializes in bumping, Cu pillar, RDL, and testing services for 12" wafers while investing in R&D for fan-out, TSV, interposer, and 3D technologies. With over a decade of experience, SJ Semi aims to support advancements in the semiconductor market.
ProBio
Series C in 2023
ProBio Inc. is a one-stop biopharmaceutical R&D and production platform. It provides end-to-end services for cell and gene therapy drugs, vaccine and biopharmaceutical discovery, antibody protein drugs.
ClinBrain
Series C in 2022
ClinBrain develops a hospital information integration platform aimed at improving healthcare services through the digitization and standardization of patient data alongside medical and clinical data. This platform is designed to enhance the efficiency of medical research by providing hospitals with comprehensive healthcare big data services. By facilitating the integration of diverse data sources, ClinBrain supports healthcare professionals in making informed decisions and advancing medical research initiatives.
VectorBuilder
Series C in 2022
VectorBuilder is an online platform specializing in vector cloning and gene delivery solutions, catering to a range of needs from basic scientific research to clinical applications. The platform enables researchers to design and order custom gene delivery vectors efficiently, streamlining the process of vector construction and production. VectorBuilder offers a comprehensive suite of services, including vector customization, virus packaging, and advanced capabilities in adeno-associated virus capsid engineering. Additionally, the company provides Contract Research Organization (CRO) services and operates state-of-the-art facilities compliant with Good Manufacturing Practices (GMP), ensuring high-quality gene delivery tools for life sciences research and drug development.
Shuhai Supply Chain
Series B in 2022
Shuhai Supply Chain Logistics is a supply chain service provider specializing in solutions for the food industry, particularly catering businesses. Established in June 2011 and headquartered in Beijing, China, the company offers a comprehensive range of services that include sales, procurement, production, quality assurance, warehousing, and transportation. Shuhai operates a modern cold chain logistics center and food processing plants, ensuring the delivery of fresh and high-quality ingredients to restaurant owners. Recognized by industry authorities and customers alike, Shuhai has emerged as a benchmark enterprise in the supply chain field, highlighting its commitment to excellence in service delivery.
Leadrive
Series C in 2022
LEADRIVE is a technology company specializing in the research, development, production, and sales of drive solutions for new energy vehicles, as well as high-performance domestic power semiconductor modules. The company develops advanced motor controllers and power modules tailored for new energy vehicles, which have been adopted by over ten models from leading domestic and international OEMs and Tier-1 suppliers. In addition to its focus on vehicle technology, LEADRIVE invests in innovative solutions for renewable energy sources, including wind and solar power, and energy storage systems. The company has achieved significant advancements in localizing power semiconductor modules and collaborates with Rohm Semiconductor to enhance the development of silicon carbide modules. This partnership aims to improve efficiency and performance across various applications, from semiconductor devices to vehicle-level integration.
APTBIO
Series B in 2022
APTBIO was initiated by Shanghai Institutes for Biological Sciences under Chinese Academy of Sciences in 2004, and is mainly engaged in the application of mass spectrometry technology. The so-called mass spectrometry technology is to measure the quality of protein molecules to carry out the identification of protein molecules, the modification of protein molecules and the study of protein molecule interactions.
Tianfu
Series C in 2022
Tianfu is a software enterprise. The company serves domestic and foreign manufacturing companies, domestic military units, universities, and scientific research institutes. The company's services include smart design solutions, industrial AI operation and maintenance, and software custom development. It also provides customized development services for corporate customers, including CAE pre-processing development.
Joymed Technology
Series B in 2022
JoyMed Technology specializes in the research and development, registration, and manufacturing of medical devices, offering comprehensive solutions to medical equipment manufacturers. The company focuses on creating innovative and reliable technologies while ensuring high-quality product standards. By providing services such as device design, risk management, marketing, and product verification and validation, JoyMed Technology helps clients streamline their processes and reduce time to market. The firm aims to be a trusted partner for both domestic and international medical device companies, particularly assisting small and medium-sized enterprises in navigating the complexities of the medical product market. Through a flexible cooperation model and experienced team design, JoyMed Technology seeks to foster mutual growth with its customers.
TBSTest
Venture Round in 2022
TBSTest Technology is a developer and manufacturer of automatic test equipment for integrated circuits, specializing in ultra-large-scale integrated circuit testing. Founded in 2017 and headquartered in Beijing, China, with additional offices in Xi’an and Shanghai, as well as Suwon, South Korea, the company provides a comprehensive range of products, including test boards, software solutions, and memory systems. TBSTest Technology also offers pre-sales and after-sales support for its equipment, accessories, and software systems, along with application development projects. The company serves a diverse clientele, including clients engaged in integrated circuit design and production, as well as scientific research institutions and educational establishments.
Lipinyun
Series B in 2022
Lipinyun is a tencent strategic investment company. They offer a full-process intelligent sales model, from customer acquisition and screening to customer management and digital asset accumulation, for enterprises diverse sales ecology. Their integration solution helps enterprises realize the upgrade and iteration of digital business.
ZHIYI TECH
Series B in 2022
Zhiyi Tech develops a supply chain platform for intelligent clothing design. They offer services for digitalized trend forecasting, design selection, and supply chain organization. They provide clothing companies with core functions such as fashion trend prediction, design empowerment, and style recommendation, and expand to the downstream of the industrial chain via the SaaS portal, providing one-stop design and flexible production supply chain platform services.
Qingwei Intelligent Technology
Series B in 2022
Qingwei Intelligent Technologies creates artificial intelligence chips that may be reconfigured to improve energy efficiency. The company's chips are designed with low power consumption, intelligent speech and visual features in mind, providing customers with a better consumer electronics experience and application.
Medilink Therapeutics
Series B in 2022
MediLink Therapeutics is a biotechnology company based in Suzhou, China, specializing in the development of next-generation antibody-drug conjugates (ADCs). The company aims to address significant unmet medical needs in China by creating innovative therapeutics that target cancer while minimizing damage to healthy cells. MediLink Therapeutics is committed to enhancing patient outcomes through its research and development efforts, which include conducting multicenter clinical trials and engaging in cross-border collaborations to generate global value. By focusing on ADCs, the company strives to improve the efficacy of cancer treatments while ensuring patient safety during therapy.
Inceptio Technology
Series B in 2022
Inceptio Technology, founded in 2018 and based in Shanghai, China, specializes in the development of autonomous driving trucks aimed at transforming line-haul logistics. The company offers a nationwide freight network and provides a Transportation-As-A-Service model that enhances the security, efficiency, and cost-effectiveness of logistics operations. Utilizing advanced technologies such as artificial intelligence, new energy solutions, and logistics big data, Inceptio's heavy-duty trucks deliver innovative and safe logistics solutions tailored for logistics companies. Additionally, the company has established research and development centers in both Shanghai and Silicon Valley to further its technological advancements.
Zhipu AI
Series B in 2022
Zhipu AI is a data company focused on developing an AI-based large model platform that offers API services tailored to various customer needs. The company provides a range of smart application products, including the scientific and technological information analysis engine "AMiner" and AI cognitive engines such as CodeGeeX and CogView. These tools are designed to help users automate and optimize digital tasks, thereby reducing the required manual labor. Zhipu AI's advanced applications are built on its General Language Model (GLM) series, capable of handling tasks in both Chinese and English, making its offerings versatile and applicable across different linguistic contexts.
Hoteam Software
Series C in 2022
Hoteam Software is a provider of intelligent manufacturing solutions aimed at transforming enterprise operations. The company emphasizes independent innovation and the development of controllable industrial software to support the advancement of China's industrial sector. Hoteam Software specializes in 3D software and offers a comprehensive range of services, including computer-aided design (CAD), computer-aided manufacturing (CAM), computer-aided process planning (CAPP), product data management (PDM), product lifecycle management (PLM), manufacturing execution systems (MES), warehouse management systems (WMS), and supplier relationship management (SRM). By leveraging its technology platforms, Hoteam Software enables industrial enterprises to enhance work efficiency and reduce operational costs through three-dimensional design, intelligent management, and visualization capabilities.
Singlomics
Series B in 2022
Singlomics uses single-cell sequencing technology to develop antibody drugs for the treatment of infectious diseases and cancers.
Zshield
Series C in 2022
Zshield Inc. is a Beijing-based company specializing in cyberspace data security and big data business risk management. Established in 2014, it is recognized as the first high-tech firm in China to leverage big data technologies in addressing emerging information security vulnerabilities. Zshield develops advanced integrated information security solutions that utilize lightweight virtualization, deep learning, and big data analysis to provide effective monitoring of server and terminal security. Its offerings include a comprehensive information security platform and the AndunTM ZS-ISP, which supports both government and enterprise clients in navigating the complexities of modern computing environments, including cloud computing and mobile applications. As traditional security measures struggle to cope with new threats, Zshield's innovative approach aims to fortify businesses against the evolving landscape of information security challenges.
Beijing Tianxing
Series B in 2022
Beijing Tianxing is a clinical solutions company for sports medicine for implants, arthroscopy devices, and sports medicine equipment.
Leapstack
Series C in 2021
Leapstack is an insurance technology company based in Shanghai, with additional offices in Beijing and Nanjing. Founded in February 2016, it focuses on developing big data artificial intelligence solutions tailored for commercial insurance companies and social security management agencies. The company's platform enhances the insurance claims process by offering services such as risk control monitoring, post-medical reimbursement, anti-fraud measures, and compliance identification. By addressing inefficiencies in the industry, Leapstack aims to improve operational effectiveness and provide comprehensive data analysis and management tools for its clients.
Xbiome
Series B in 2021
Xbiome is a pioneering pharmaceutical company in China focused on intestinal micro-ecology, utilizing artificial intelligence to enhance gut health management for a population of 1.3 billion. The company specializes in developing microbial pharmaceuticals aimed at treating microecological intestinal disorders. By analyzing both patient and donor intestinal flora, Xbiome accelerates the creation of effective treatments. Their innovative approach includes the use of living biological drugs and microbial small molecule modulators, which aim to provide patients with relief from various gastrointestinal diseases.
ColorTech Bio
Series B in 2021
ColorTech Bio researches and develops precision molecular diagnostic equipment. It offers medical devices to improve biotechnology services and solutions. ColorTech Bio was founded in 2018 and is based in Suzhou, China.
Jifan Biotechnology
Series B in 2021
Jifan Biotechnology is a biotechnology firm that provides molecular biology reagents, diagnostic raw materials, and kits for research.
LePure Biotech
Series B in 2021
Lechun Biology is an enterprise engaged in disposable products and leak detection equipment in the biotechnology and pharmaceutical industries. The company develops and produces disposable biopharmaceutical process equipment and consumables. The products are used for the storage, transportation, filling and leak detection of various samples in biosimilars, vaccines and other biopharmaceutical processes. The core product is a disposable storage bag. Recently completed B+ round of financing. This round of financing will be mainly used for the development of a number of innovative new products, the establishment of a US R&D center, the integration of the upstream industrial chain, the securing of the supply chain, and the expansion of the R&D market operation team at home and abroad.
Eswin
Series C in 2021
Eswin provides IC application solutions in mobile devices, smart homes, smart transportation, industrial IoT, produces 12-inch monocrystalline silicon polished wafers and epitaxial wafers, and delivers rear-end IC packaging and testing services, according to its website. It operates R&D centers in China, the U.K., and South Korea, and has production facilities in Xi'an, Chengdu, Hefei and Suzhou.
Wuxi Biortus Biosciences
Series B in 2021
Wuxi Biortus Biosciences Co. Ltd. is a contract research organization based in Jiangyin, China, specializing in research and development services that support drug discovery. Founded in 2009, the company offers a range of services, including recombinant protein production, in vitro assays and screening, medicinal chemistry, structural biology, and target validation. Wuxi Biortus Biosciences is recognized for its commitment to quality and innovation, having established five advanced research platforms that enhance its capabilities in drug development. The company’s R&D team has developed various innovative techniques, some of which have been patented, further solidifying its role in the biotechnology sector. It operates as a subsidiary of Jiangsu Shuangliang Group Company Ltd.
ForQaly
Series B in 2021
ForQaly specializes in the development of minimally invasive ventricular assist devices designed to treat heart failure patients. The company focuses on creating therapeutic devices that enhance circulation while ensuring affordability for patients. Their products are characterized by features such as reduced trauma, high auxiliary flow, and user-friendly design, providing healthcare professionals with effective solutions for improving patient health. By combining innovation with accessibility, ForQaly aims to address the clinical needs of patients suffering from heart conditions.
H.Extract
Series C in 2021
H.Extract is a company focused on the research, development, promotion, and sales of pharmaceutical ERP solutions. As a leading brand in China's pharmaceutical distribution sector, H.Extract has implemented its Cloud ERP System in over 40,000 pharmacies nationwide. The company formed a strategic partnership with Tencent Cloud and WeChat Pay in 2016 to enhance the efficiency of the medicine distribution industry, particularly in pharmaceutical wholesale and chain drugstores. With 14 years of experience, H.Extract leverages its technical expertise and management skills to cater to a diverse client base, including major players in the pharmaceutical sector such as Harbin Pharmaceutical Group and Hainan Zhangzhongjing Dispensary. The company's commitment to innovation and high-quality service aims to streamline operations within the pharmaceutical supply chain.
HC Scientific
Series B in 2021
HC Scientific (Chengdu) L.L.C., founded in early 2016, focuses on developing intelligent solutions within the life sciences sector. The company aims to be a trusted partner for global clients by offering innovative products, including genetic testing instruments, reagents, and software. These products are primarily used in clinical molecular diagnostics, health gene testing, and agricultural molecular breeding. HC Scientific is recognized as a national high-tech enterprise, emphasizing autonomous research and the development of intellectual property. The company participates in significant national and provincial scientific initiatives and is supported by a team of experts, including returning PhDs. Its product offerings streamline complex tasks for life science practitioners, delivering high-throughput, automated, and cost-effective genetic testing solutions while creating value for collaborative partners.
LYNK Pharmaceuticals
Series B in 2021
LYNK Pharmaceuticals is a biotech company focusing on the discovery and development of novel medicines to treat oncology, immunology, and inflammatory diseases. The company was founded in 2018 and is headquartered in Hangzhou, Zhejiang, China.
Berry Oncology
Series B in 2021
Berry Oncology develops medical technology intended to improve cancer prevention and tumor diagnosis. It offers genetic diagnosis solutions from early diagnosis to mid-late monitoring that can solve clinical problems in the direction of several malignant tumors, providing patients with a higher quality of life and reduced risk of cancer. The company's mission is early diagnosis and early treatment of all tumors, all patients receive precise treatment. Along with its vision to become a global icon in the field of early screening and early diagnosis of tumors and a leader in China's tumor gene testing market.
QANDA(Mathpresso)
Series C in 2021
With the mission to provide the most effective education for all, QANDA(Mathpresso) operates the world’s leading learning platform, QANDA, an AI-based learning app that allows students of all levels to receive instant answers and customized learning sources. Recognized for its technological advances, QANDA(Mathpresso) was selected as GSV Edtech 150, national representative of Google AI for Social Good APAC event in 2018, and guest speaker at AWS Public Sector Summit ASEAN in 2019. Since 2015, QANDA(Mathpresso) has raised over $105 million in total from investors including SoftBank Ventures Asia, Legend Capital, Mirae Asset Investment, GGV, and Goodwater Capital. Headquartered in Seoul, QANDA(Mathpresso) has offices in Tokyo, Hanoi, Jakarta, and Bangkok.
YEASEN Biotechnology
Series B in 2021
Yeasen is a biotechnology company that provides molecular enzymes, proteins, antibodies, nucleic acids, and cells. They produce fields of life science research, diagnosis and detection, and biomedicine.
Horizon Robotics
Series C in 2021
Horizon Robotics is a prominent provider of advanced driver assistance systems (ADAS) and autonomous driving solutions specifically designed for passenger vehicles. The company develops proprietary software and hardware that integrate advanced algorithms and specialized processing capabilities. These technologies form the foundation for enhanced driving automation, aiming to improve both safety and the overall experience for drivers and passengers. By focusing on innovative solutions, Horizon Robotics plays a key role in the evolution of assisted and autonomous driving.
Bloks Technology Group
Series B in 2021
Bloks Group uses innovative technology to create the ultimate product experience and create long-term value for users. The group currently has four core business segments, including Bruker Building Blocks, Bruker Animation, Bubble Education, and Brock Education. Bloks Group strives to create a whole ecological industry chain with "building blocks +" as the core, and at the same time applies to build blocks to various application scenarios, and lays out a complete T (Toy toy) + A (Animation animation) + G (Game game) +E (Education Education) industry vision.
Dearer Medical
Series B in 2021
Dearer Medical is a medical device company based in China that specializes in the development, production, and sales of eye-related products, particularly contact lenses. The company emphasizes research and development to create both practical and fashionable color contact lenses, catering to a diverse customer base. Through its innovative approach, Dearer Medical aims to enhance the user experience while addressing the aesthetic and functional needs of contact lens wearers.
Fiture Technology
Series B in 2021
Fiture, a fitness technology company, is redefining the home fitness scenarios through intelligent hardware and AI-empowered fitness content.
StoneWise
Series B in 2021
StoneWise is a technology company established in 2018 that focuses on enhancing the drug discovery process through artificial intelligence. The company aims to transform traditional drug research and development by implementing a dual-engine model that combines advanced AI technology with expert systems. Its platform utilizes cutting-edge technologies, including microfluidics, computational chemistry, computational biology, pharmacology, and clinical medicine, to offer integrated solutions for pharmaceutical companies. These solutions encompass a variety of tools, such as medical knowledge graphs, molecular generation and design, and predictions of reaction products and synthetic pathways. By leveraging this innovative platform, StoneWise seeks to improve the efficiency and success rates of early-stage drug discoveries. The company collaborates with both domestic and international experts in various scientific fields, and maintains a state-of-the-art facility to stay abreast of the latest advancements in drug discovery.
Sciwind Biosciences
Series B in 2021
Sciwind Biosciences is a developers of drugs intended to treat metabolic disorders. The company's drugs contain protein and peptide candidates for non-alcoholic steatohepatitis, enabling physicians to treat their patients in an enhanced way.
Liangyihui
Series C in 2021
Suzhou Liangyihui Network Technology Co., Ltd. operates an authoritative online education and information platform focused on oncology. Based in Shanghai, China, the company collaborates with numerous reputable hospitals and institutions, both domestically and internationally, to address the information asymmetry in the cancer field. Liangyihui provides a comprehensive range of educational materials related to tumor treatment, including medical cases, conference information, online courses, and research reports. This platform serves as a valuable resource for oncologists and aims to enhance public understanding of cancer, promoting scientific knowledge and supporting efforts to prevent and combat the disease.
Exegenesis Bio
Series B in 2021
Exegenesis is going to develop new medicine based on gene therapy and focuses on China and the global market. The team consists of experienced professionals, including gene therapy drug design, preclinical studies and clinical development.
Jinqirui Biology
Series B in 2020
Jinqirui Biology is a biotechnology company that focuses on the research and development, manufacturing, production & sales of vitro diagnostics equipment and reagents.
Wangdiantong
Series C in 2020
Wangdiantong ERP is a provider of enterprise-level e-commerce solutions that facilitate the integration of online and offline retail operations. The company's services encompass a range of functionalities, including inventory management, order processing, purchasing, after-sales service, and customer relationship management. By supporting major platforms such as Taobao, Tmall, Jingdong, Amazon, and Alibaba, Wangdiantong enables businesses to effectively manage multi-warehouse systems and streamline operations for both online stores and physical retail locations. Additionally, the company offers intelligent warehouse solutions and cloud-based services designed to assist enterprises in transitioning to digital management and scaling their operations efficiently.
Kunya Medical
Series C in 2020
Kunya Medical is a provider of medical equipment management services focused on enhancing the maintenance and operational efficiency of hospital equipment. The company offers comprehensive services, including the maintenance and hosting of hospital imaging and radiation equipment, as well as installation, debugging, and repair of large and medium-sized medical devices. Kunya Medical also supplies spare parts and management software, facilitating improved oversight and longevity of clinical medical equipment for hospitals. By outsourcing these critical functions, Kunya Medical aims to help healthcare facilities optimize their equipment management and extend the lifecycle of their medical assets.
Xbiome
Series B in 2020
Xbiome is a pioneering pharmaceutical company in China focused on intestinal micro-ecology, utilizing artificial intelligence to enhance gut health management for a population of 1.3 billion. The company specializes in developing microbial pharmaceuticals aimed at treating microecological intestinal disorders. By analyzing both patient and donor intestinal flora, Xbiome accelerates the creation of effective treatments. Their innovative approach includes the use of living biological drugs and microbial small molecule modulators, which aim to provide patients with relief from various gastrointestinal diseases.
GalaxySpace
Series C in 2020
GalaxySpace is a satellite manufacturer based in Haidian, China, founded in 2016. The company specializes in developing and building a low Earth orbit (LEO) broadband satellite constellation and a 5G communication network. GalaxySpace offers various satellite applications, including monitoring systems for airports, parking, and oil reserves, as well as land assessment services. Their product range includes communication payloads, phased array antennas, power management systems, solar panels, and core platform components. Additionally, the company provides one-stop artificial intelligence satellite launch services, facilitating convenient communication and information access for clients while reducing network costs.
Aqrose Technology
Series B in 2020
Aqrose Technology Co., Ltd., founded in 2017 from the AI Lab of Tsinghua University, specializes in the application of advanced artificial intelligence and machine vision technologies in industrial settings. The company provides a range of products, including its standardized intelligent industrial vision platform AIDI and the AIPICK intelligent inspecting and sorting robot, which utilize 3D vision technology for automation. Aqrose's solutions support various sectors such as consumer electronics, automotive, new energy, pharmaceuticals, semiconductors, and logistics, enhancing manufacturing processes and product quality. With deployments in over 100 factories, including leading enterprises in advanced manufacturing and smart logistics, Aqrose is committed to empowering its clients through innovative technology.
GensKey
Series C in 2020
GensKey is a medical diagnostic service provider specializing in genetic testing for pathogen diagnosis. Utilizing high-throughput sequencing technology and intelligent algorithm analysis, GensKey addresses traditional challenges such as low detection rates, lengthy processes, and diagnostic accuracy. This innovative approach allows for timely and precise diagnoses for patients suffering from severe infections, ultimately improving patient outcomes by facilitating quicker access to appropriate medical interventions.
Hemu (China) Biological Engineering
Series B in 2020
Hemu (China) Biological Engineering is a Chinese blood vessel intervention medical equipment firm.
HEMO BIOENGINEERING
Series B in 2020
HEMO BIOENGINEERING develops and provides innovative interventional medical devices to patients.
Leadrive
Series B in 2020
LEADRIVE is a technology company specializing in the research, development, production, and sales of drive solutions for new energy vehicles, as well as high-performance domestic power semiconductor modules. The company develops advanced motor controllers and power modules tailored for new energy vehicles, which have been adopted by over ten models from leading domestic and international OEMs and Tier-1 suppliers. In addition to its focus on vehicle technology, LEADRIVE invests in innovative solutions for renewable energy sources, including wind and solar power, and energy storage systems. The company has achieved significant advancements in localizing power semiconductor modules and collaborates with Rohm Semiconductor to enhance the development of silicon carbide modules. This partnership aims to improve efficiency and performance across various applications, from semiconductor devices to vehicle-level integration.
Haihe Biopharma
Series B in 2020
Haihe Biopharma is dedicated to the discovery, development, and commercialization of innovative anti-tumor drugs aimed at addressing complex diseases. The company specializes in pharmacological efficacy evaluation and offers a range of products, including novel topoisomerase I inhibitors and highly selective oral c-Met inhibitors. By focusing on these advancements, Haihe Biopharma seeks to enhance health outcomes for patients and improve the quality of research in the pharmaceutical field.
Tongcheng Shenghuo
Series C in 2020
Tongcheng Life is a community O2O group purchase service platform. With the community as a unit, it establishes a community sales office and completes offline delivery. The platform provides supply, logistics, storage and after-sales support. It mainly provides primary edible agricultural products, food, daily necessities, flowers and gardening, and crafts. , Beauty products and other services.
Eswin
Series B in 2020
Eswin provides IC application solutions in mobile devices, smart homes, smart transportation, industrial IoT, produces 12-inch monocrystalline silicon polished wafers and epitaxial wafers, and delivers rear-end IC packaging and testing services, according to its website. It operates R&D centers in China, the U.K., and South Korea, and has production facilities in Xi'an, Chengdu, Hefei and Suzhou.
Uditech
Series B in 2020
Uditech is a high-tech enterprise with technology as its core and innovation-oriented.
iBeiDiao
Series B in 2020
iBeiDiao is an intelligent employee background investigation service-providing company. They provide objective background-checking services and employee onboarding management solutions for employees using artificial intelligence, providing employee credit reference information for enterprises.
Wangdiantong
Series B in 2020
Wangdiantong ERP is a provider of enterprise-level e-commerce solutions that facilitate the integration of online and offline retail operations. The company's services encompass a range of functionalities, including inventory management, order processing, purchasing, after-sales service, and customer relationship management. By supporting major platforms such as Taobao, Tmall, Jingdong, Amazon, and Alibaba, Wangdiantong enables businesses to effectively manage multi-warehouse systems and streamline operations for both online stores and physical retail locations. Additionally, the company offers intelligent warehouse solutions and cloud-based services designed to assist enterprises in transitioning to digital management and scaling their operations efficiently.
Healing Paper
Series B in 2020
Healing Paper operates a platform focused on enhancing access to cosmetic surgery services while promoting transparency and affordability. The company utilizes information and communication technology to provide patients with estimates for necessary procedures, honest reviews, and special pricing options. In addition to connecting patients with cosmetic treatment options, Healing Paper fosters a real-time community for sharing experiences and offers management tools for post-surgery care. By balancing information between medical professionals and patients, Healing Paper aims to improve the quality of cosmetic beauty services and make them more accessible.
Harbour BioMed
Series B in 2020
Harbour BioMed is a developer of bio-therapeutics aimed at immuno-oncology and inflammatory diseases. The company engages in discovery and development programs that are centered around two patented transgenic mouse platforms for generating both fully human monoclonal antibodies (H2L2) and heavy chain only antibodies (HCAb) based immune cell engager (HBICETM) bispecific antibodies, thereby enabling medical professionals to generate potential therapeutic antibodies and accelerate drug discovery and development.
Lunit
Series C in 2019
Lunit Inc. is a medical AI software company based in Seoul, South Korea, specializing in advanced algorithms for medical image analysis and general object detection. The company develops solutions for various medical imaging modalities, including digital chest X-ray, digital mammography, digital pathology, and fundus photography. Lunit aims to enhance clinical decision-making for physicians by leveraging machine learning technology to provide accurate and consistent diagnoses. Its product offerings include Lunit INSIGHT CXR for chest X-rays, Lunit INSIGHT MMG for mammography, and Lunit SCOPE, which includes AI-powered biomarkers for immuno-oncology. Lunit's deep learning technology has been recognized for its capabilities, ranking among the top in prestigious image recognition competitions, highlighting its innovative approach to processing medical imaging data and utilizing weakly labeled data for improved pattern recognition.
Nanovision
Series B in 2019
Nanovision Technology is located in Zhongguancun Yongfeng high-tech industrial base, with thousands of square meters of R&D foundation in Yonyou Industrial Park. We also set up a subsidiary company in Chengdu. their company is a high-tech enterprise focused on high-speed and high-precision radiology imaging.Nanovison focus in static CT,x-ray CMOS detectors and x-ray imaging software, etc.Which can be widely used in medical, industrial, security and other fields.
Dongfang Weiyin
Series C in 2019
Dongfang Weiyin is a small and micro enterprise financial service platform.
Suzhou Ribo Life Science
Series C in 2019
Suzhou Ribo Life Science Co., Ltd. specializes in the development of nucleic acid drugs utilizing RNA interference (RNAi) technology, with a particular focus on treating liver diseases. Founded in 2007 and based in Kunshan, China, the company engages in various aspects of drug development, including drug discovery, siRNA design and screening, chemical modification, delivery technology, pharmacodynamics and pharmacokinetics studies, safety evaluation, and clinical trials. Suzhou Ribo Life Science offers siRNA therapeutics targeting conditions such as Hepatitis B, breast carcinoma, liver fibrosis, liver carcinoma, and HIV. The company has established a strategic partnership with Quark Pharmaceuticals, Inc. to enhance its research and development capabilities.
RT-Thread
Series B in 2019
RT-Thread was born in 2006, it is an open source, neutral, and community-based real-time operating system (RTOS). RT-Thread is mainly written in C language, easy to understand and easy to port(can be quickly ported to a wide range of mainstream MCUs and module chips). It applies object-oriented programming methods to real-time system design, making the code elegant, structured, modular, and very tailorable. RT-Thread has a Standard version and Nano version. For resource-constrained microcontroller (MCU) systems, the NANO kernel version that requires only 3KB Flash and 1.2KB RAM memory resources can be tailored with easy-to-use tools; And for resource-rich IoT devices, RT-Thread can use the on-line software package management tool, together with system configuration tools, to achieve intuitive and rapid modular cutting, seamlessly import rich software packages, thus achieving complex functions like Android's graphical interface and touch sliding effects, smart voice interaction effects, and so on.
Xbiome
Series B in 2019
Xbiome is a pioneering pharmaceutical company in China focused on intestinal micro-ecology, utilizing artificial intelligence to enhance gut health management for a population of 1.3 billion. The company specializes in developing microbial pharmaceuticals aimed at treating microecological intestinal disorders. By analyzing both patient and donor intestinal flora, Xbiome accelerates the creation of effective treatments. Their innovative approach includes the use of living biological drugs and microbial small molecule modulators, which aim to provide patients with relief from various gastrointestinal diseases.
dMed
Series B in 2019
dMed is a full-service Clinical Contract Research Organization that provides industry solutions to pharma and medical device companies. Its business covers consulting, regulatory affairs & strategy, early clinical development, clinical science & medical affairs, clinical operations, biostatistics & programming, data management, drug safety & pharmacovigilance, quality assurance, and information solutions. dMed has set up offices in major cities, including Shanghai, Beijing, Wuhan, New York, Washington, San Francisco, and Brussels, and it employs around 600 professionals globally, among them 60% holds master above degree and 25% with more than 10 years working experiences.
QANDA(Mathpresso)
Series B in 2019
With the mission to provide the most effective education for all, QANDA(Mathpresso) operates the world’s leading learning platform, QANDA, an AI-based learning app that allows students of all levels to receive instant answers and customized learning sources. Recognized for its technological advances, QANDA(Mathpresso) was selected as GSV Edtech 150, national representative of Google AI for Social Good APAC event in 2018, and guest speaker at AWS Public Sector Summit ASEAN in 2019. Since 2015, QANDA(Mathpresso) has raised over $105 million in total from investors including SoftBank Ventures Asia, Legend Capital, Mirae Asset Investment, GGV, and Goodwater Capital. Headquartered in Seoul, QANDA(Mathpresso) has offices in Tokyo, Hanoi, Jakarta, and Bangkok.
GalaxySpace
Series B in 2019
GalaxySpace is a satellite manufacturer based in Haidian, China, founded in 2016. The company specializes in developing and building a low Earth orbit (LEO) broadband satellite constellation and a 5G communication network. GalaxySpace offers various satellite applications, including monitoring systems for airports, parking, and oil reserves, as well as land assessment services. Their product range includes communication payloads, phased array antennas, power management systems, solar panels, and core platform components. Additionally, the company provides one-stop artificial intelligence satellite launch services, facilitating convenient communication and information access for clients while reducing network costs.
GKHT Medical Technology
Series C in 2019
Guoke Hengtai (Beijing) Medical Technology Co., Ltd., established in February 2013, is a company based in the Yizhuang Economic and Technological Development Zone of Beijing. It operates under the umbrella of Oriental Science and Technology Holding Group Co., Ltd., a subsidiary of the State-owned Assets Supervision and Administration Commission of the Chinese Academy of Sciences. The company specializes in the distribution and direct sales of medical devices, offering a range of professional services, including warehousing logistics, distribution channel management, and hospital SPD operation management. Since its inception, Guoke Hengtai has experienced significant growth, achieving a compound annual growth rate exceeding 50% over four years and embarking on an initial public offering journey in 2017.
AgotoZ
Series B in 2019
AgotoZ Technology, established in 2017 as Guanmai Technology (Beijing) Co., Ltd., specializes in providing high-speed network transmission services tailored for enterprises. The company focuses on WAN high-speed transmission core technology, big data computing, and security defense solutions. By leveraging its capabilities in resource calculation and security, AgotoZ aims to enhance the efficiency and interoperability of enterprise networks. Through independent research and development, it offers advanced technologies and products designed to meet the evolving needs of businesses seeking reliable and efficient network transmission solutions.
Tongcheng Shenghuo
Series B in 2019
Tongcheng Life is a community O2O group purchase service platform. With the community as a unit, it establishes a community sales office and completes offline delivery. The platform provides supply, logistics, storage and after-sales support. It mainly provides primary edible agricultural products, food, daily necessities, flowers and gardening, and crafts. , Beauty products and other services.
Inossem
Series B in 2019
Inossem is a technology company dedicated to aiding organizations in their digital transformation efforts, with a primary focus on enhancing operational efficiency and fostering business growth. Headquartered in Montreal, Quebec, Inossem Canada operates as a subsidiary and provides consulting services across the country, specializing in research and development for enterprise applications. Its offerings include corporate advisory services, digital supply chain solutions, and digital workforce tools. The digital supply chain segment features products like InStock, an intelligent storage solution, and InData, which focuses on master data management, both leveraging AI and IoT technologies. Additionally, Inossem's supply chain optimization product, InoVAT, aims to enhance warehouse and inventory management capabilities. In the realm of digital workforce solutions, ProcessGo facilitates rapid data and process integration through automation, providing clients with streamlined operational capabilities. Through its innovative products and services, Inossem supports organizations in achieving sustainable growth by leveraging industry-specific insights and global digital practices.
Shuhai Supply Chain
Series B in 2019
Shuhai Supply Chain Logistics is a supply chain service provider specializing in solutions for the food industry, particularly catering businesses. Established in June 2011 and headquartered in Beijing, China, the company offers a comprehensive range of services that include sales, procurement, production, quality assurance, warehousing, and transportation. Shuhai operates a modern cold chain logistics center and food processing plants, ensuring the delivery of fresh and high-quality ingredients to restaurant owners. Recognized by industry authorities and customers alike, Shuhai has emerged as a benchmark enterprise in the supply chain field, highlighting its commitment to excellence in service delivery.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.